{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:29:22Z","timestamp":1785792562087,"version":"3.56.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11914-018-0486-0","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T06:05:36Z","timestamp":1538719536000},"page":"693-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["CKD-MBD: from the Pathogenesis to the Identification and Development of Potential Novel Therapeutic Targets"],"prefix":"10.1007","volume":"16","author":[{"given":"Rosilene Motta","family":"Elias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida","family":"Dalboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina E.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M. A.","family":"Moys\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"issue":"7","key":"486_CR1","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O\u2019Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.","journal-title":"PLoS One"},{"issue":"6","key":"486_CR2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/13696998.2017.1288127","volume":"20","author":"RB McQueen","year":"2017","unstructured":"McQueen RB, Farahbakhshian S, Bell KF, Nair KV, Saseen JJ. Economic burden of comorbid chronic kidney disease and diabetes. J Med Econ. 2017;20(6):585\u201391.","journal-title":"J Med Econ"},{"issue":"4","key":"486_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semnephrol.2016.05.008","volume":"36","author":"V Wang","year":"2016","unstructured":"Wang V, Vilme H, Maciejewski ML, Boulware LE. The economic burden of chronic kidney disease and end-stage renal disease. Semin Nephrol. 2016;36(4):319\u201330.","journal-title":"Semin Nephrol"},{"issue":"6","key":"486_CR4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00592-018-1133-z","volume":"55","author":"G Penno","year":"2018","unstructured":"Penno G, Solini A, Bonora E, Orsi E, Fondelli C, Zerbini G, et al. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study. Acta Diabetol. 2018;55(6):603\u201312.","journal-title":"Acta Diabetol"},{"issue":"6","key":"486_CR5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","volume":"80","author":"CA Herzog","year":"2011","unstructured":"Herzog CA, Asinger RW, Berger AK, Charytan DM, Diez J, Hart RG, et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011;80(6):572\u201386.","journal-title":"Kidney Int"},{"issue":"11","key":"486_CR6","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69(11):1945\u201353.","journal-title":"Kidney Int"},{"issue":"4","key":"486_CR7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31(4):607\u201317.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"486_CR8","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208\u201318.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"486_CR9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI100328","volume":"9","author":"F Albright","year":"1931","unstructured":"Albright F, Bauer W, Cockrill JR, Ellsworth R. Studies on the physiology of the Parathyroid glands: II. The relation of the serum calcium to the serum phosphorus at different levels of parathyroid activity. J Clin Invest. 1931;9(4):659\u201377.","journal-title":"J Clin Invest"},{"issue":"2467","key":"486_CR10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.95.2467.388","volume":"95","author":"SH Liu","year":"1942","unstructured":"Liu SH, Chu HI. Treatment of renal osteodystrophy with dihydrotachysterol (A.T.10) and iron. Science. 1942;95(2467):388\u20139.","journal-title":"Science"},{"key":"486_CR11","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/ki.2011.23","volume":"79121","author":"E Slatopolsky","year":"2011","unstructured":"Slatopolsky E. The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder. Kidney Int. 2011;79121:S3\u20138.","journal-title":"Kidney Int"},{"issue":"5","key":"486_CR12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/kisup.2013.88","volume":"3","author":"OM Kuro","year":"2013","unstructured":"Kuro OM. A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease. Kidney Int Suppl. 2013;3(5):420\u20136.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"486_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.ajkd.2016.05.022","volume":"69","author":"A Tong","year":"2017","unstructured":"\u2022 Tong A, Manns B, Hemmelgarn B, Wheeler DC, Evangelidis N, Tugwell P, et al. Establishing core outcome domains in hemodialysis: report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop. Am J Kidney Dis. 2017;69(1):97\u2013107 This study shows a new approach driving clinical trials focusing in quality of life and survival, giving less importance to surrogate markers.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"486_CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","volume":"26","author":"LF Bonewald","year":"2011","unstructured":"Bonewald LF. The amazing osteocyte. J Bone Miner Res. 2011;26(2):229\u201338.","journal-title":"J Bone Miner Res"},{"key":"486_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2369-15-69","volume":"15","author":"GO Ferrari","year":"2014","unstructured":"Ferrari GO, Ferreira JC, Cavallari RT, Neves KR, dos Reis LM, Dominguez WV, et al. Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5\/6 nephrectomy and adenine models. BMC Nephrol. 2014;15:69.","journal-title":"BMC Nephrol"},{"issue":"6","key":"486_CR16","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.kint.2016.12.029","volume":"91","author":"FG Graciolli","year":"2017","unstructured":"\u2022 Graciolli FG, Neves KR, Barreto F, Barreto DV, Dos Reis LM, Canziani ME, et al. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease. Kidney Int. 2017;91(6):1436\u201346 This study reported the natural history of CKD-MBD as the renal function deteriorates. Authors showed the behavior of biochemical markers, as well as of osteocyte-related proteins.","journal-title":"Kidney Int"},{"issue":"2","key":"486_CR17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","volume":"5","author":"RB Oliveira","year":"2010","unstructured":"Oliveira RB, Cancela AL, Graciolli FG, Dos Reis LM, Draibe SA, Cuppari L, et al. Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol. 2010;5(2):286\u201391.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"486_CR18","doi-asserted-by":"crossref","first-page":"c74","DOI":"10.1159\/000319650","volume":"117","author":"AL Cancela","year":"2011","unstructured":"Cancela AL, Oliveira RB, Graciolli FG, dos Reis LM, Barreto F, Barreto DV, et al. Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate. Nephron Clin Pract. 2011;117(1):c74\u201382.","journal-title":"Nephron Clin Pract"},{"issue":"8","key":"486_CR19","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","volume":"27","author":"Y Sabbagh","year":"2012","unstructured":"Sabbagh Y, Graciolli FG, O'Brien S, Tang W, dos Reis LM, Ryan S, et al. Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy. J Bone Miner Res. 2012;27(8):1757\u201372.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"486_CR20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","volume":"45","author":"RC Pereira","year":"2009","unstructured":"Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone. 2009;45(6):1161\u20138.","journal-title":"Bone"},{"issue":"4","key":"486_CR21","doi-asserted-by":"crossref","first-page":"e1002427","DOI":"10.1371\/journal.pbio.1002427","volume":"14","author":"SK Murali","year":"2016","unstructured":"\u2022 Murali SK, Andrukhova O, Clinkenbeard EL, White KE, Erben RG. Excessive osteocytic Fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in hyp mice. PLoS Biol. 2016;14(4):e1002427 In this experimental research, it was demonstrated that FGF-23 inhibits bone mineralization through the inhibition of bone alkaline phosphatase.","journal-title":"PLoS Biol"},{"issue":"4","key":"486_CR22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","volume":"49","author":"Y Rhee","year":"2011","unstructured":"Rhee Y, Bivi N, Farrow E, Lezcano V, Plotkin LI, White KE, et al. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone. 2011;49(4):636\u201343.","journal-title":"Bone"},{"issue":"3","key":"486_CR23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.kint.2017.02.014","volume":"92","author":"H Komaba","year":"2017","unstructured":"\u2022 Komaba H, Kaludjerovic J, Hu DZ, Nagano K, Amano K, Ide N, et al. Klotho expression in osteocytes regulates bone metabolism and controls bone formation. Kidney Int. 2017;92(3):599\u2013611 Osteocyte-specific Klotho deletion leads to a unexpected improvement of bone formation. This effect is abrogated in CKD and hyperparathyroidism.","journal-title":"Kidney Int"},{"issue":"1","key":"486_CR24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","volume":"90","author":"N Carrillo-Lopez","year":"2016","unstructured":"\u2022 Carrillo-Lopez N, Panizo S, Alonso-Montes C, Roman-Garcia P, Rodriguez I, Martinez-Salgado C, et al. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int. 2016;90(1):77\u201389 Experimental study showing the local inhibitory effects of FGF-23 and Klotho on bone formation mediated by the increase of DKK1.","journal-title":"Kidney Int"},{"issue":"3","key":"486_CR25","doi-asserted-by":"crossref","first-page":"e0120856","DOI":"10.1371\/journal.pone.0120856","volume":"10","author":"RC Pereira","year":"2015","unstructured":"Pereira RC, Juppner H, Gales B, Salusky IB, Wesseling-Perry K. Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients. PLoS One. 2015;10(3):e0120856.","journal-title":"PLoS One"},{"issue":"6","key":"486_CR26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.kint.2017.02.026","volume":"91","author":"K Wesseling-Perry","year":"2017","unstructured":"Wesseling-Perry K. Osteocyte dysfunction and renal osteodystrophy: not just calcium and phosphorus anymore. Kidney Int. 2017;91(6):1276\u20138.","journal-title":"Kidney Int"},{"issue":"5","key":"486_CR27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2014.372","volume":"87","author":"RA Oliveira de","year":"2015","unstructured":"\u2022 de Oliveira RA, Barreto FC, Mendes M, dos Reis LM, Castro JH, Britto ZM, et al. Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int. 2015;87(5):1039\u201345 First study to show the role of sclerotin causing adynamic bone disease in patients on peritoneal dialysis.","journal-title":"Kidney Int"},{"key":"486_CR28","doi-asserted-by":"crossref","unstructured":"Santos MFP, Hernandez MJ, de Oliveira IB, Siqueira FR, Dominguez WV, Dos Reis LM, et al. Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures. J Bone Miner Metab. 2018.","DOI":"10.1007\/s00774-018-0902-7"},{"issue":"12","key":"486_CR29","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s11255-016-1387-8","volume":"48","author":"M Kanbay","year":"2016","unstructured":"Kanbay M, Solak Y, Siriopol D, Aslan G, Afsar B, Yazici D, et al. Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis. Int Urol Nephrol. 2016;48(12):2029\u201342.","journal-title":"Int Urol Nephrol"},{"issue":"15","key":"486_CR30","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 2017;377(15):1417\u201327.","journal-title":"N Engl J Med"},{"issue":"3","key":"486_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000084890","volume":"23","author":"L Martola","year":"2005","unstructured":"Martola L, Barany P, Stenvinkel P. Why do dialysis patients develop a heart of stone and bone of China? Blood Purif. 2005;23(3):203\u201310.","journal-title":"Blood Purif"},{"issue":"1","key":"486_CR32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","volume":"89","author":"V David","year":"2016","unstructured":"David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, et al. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int. 2016;89(1):135\u201346.","journal-title":"Kidney Int"},{"issue":"5","key":"486_CR33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","volume":"90","author":"S Singh","year":"2016","unstructured":"\u2022 Singh S, Grabner A, Yanucil C, Schramm K, Czaya B, Krick S, et al. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney Int. 2016;90(5):985\u201396 This study shows that FGF-23 synthesis not only is stimulated by inflammation, but can itself increase the synthesis of inflammatory cytokines by the hepatocytes.","journal-title":"Kidney Int"},{"issue":"2","key":"486_CR34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00198-015-3233-8","volume":"27","author":"L Viaene","year":"2016","unstructured":"Viaene L, Behets GJ, Heye S, Claes K, Monbaliu D, Pirenne J, et al. Inflammation and the bone-vascular axis in end-stage renal disease. Osteoporos Int. 2016;27(2):489\u201397.","journal-title":"Osteoporos Int"},{"issue":"1","key":"486_CR35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-14-1038","volume":"173","author":"MH Christensen","year":"2015","unstructured":"Christensen MH, Fenne IS, Nordbo Y, Varhaug JE, Nygard KO, Lien EA, et al. Novel inflammatory biomarkers in primary hyperparathyroidism. Eur J Endocrinol. 2015;173(1):9\u201317.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"486_CR36","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1210\/en.2014-1046","volume":"155","author":"AN Ben-awadh","year":"2014","unstructured":"Ben-awadh AN, Delgado-Calle J, Tu X, Kuhlenschmidt K, Allen MR, Plotkin LI, et al. Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes. Endocrinology. 2014;155(8):2797\u2013809.","journal-title":"Endocrinology"},{"issue":"12","key":"486_CR37","doi-asserted-by":"crossref","first-page":"8287","DOI":"10.4049\/jimmunol.175.12.8287","volume":"175","author":"N Young","year":"2005","unstructured":"Young N, Mikhalkevich N, Yan Y, Chen D, Zheng WP. Differential regulation of osteoblast activity by Th cell subsets mediated by parathyroid hormone and IFN-gamma. J Immunol. 2005;175(12):8287\u201395.","journal-title":"J Immunol"},{"issue":"3","key":"486_CR38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11914-017-0359-y","volume":"15","author":"M Neale Weitzmann","year":"2017","unstructured":"\u2022\u2022 Neale Weitzmann M, Pacifici R. Parathyroid diseases and T cells. Curr Osteoporos Rep. 2017;15(3):135\u201341 This review highlights the actions of T-cell on PTH-induced bone resorption, reinforcing the link between hyperparathyroidism, inflammation and bone loss.","journal-title":"Curr Osteoporos Rep"},{"issue":"8","key":"486_CR39","doi-asserted-by":"crossref","first-page":"e12290","DOI":"10.1371\/journal.pone.0012290","volume":"5","author":"H Tawfeek","year":"2010","unstructured":"Tawfeek H, Bedi B, Li JY, Adams J, Kobayashi T, Weitzmann MN, et al. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. PloS One. 2010;5(8):e12290.","journal-title":"PloS One"},{"issue":"3","key":"486_CR40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5527\/wjn.v5.i3.224","volume":"5","author":"SC Maung","year":"2016","unstructured":"Maung SC, El Sara A, Chapman C, Cohen D, Cukor D. Sleep disorders and chronic kidney disease. World J Nephrol. 2016;5(3):224\u201332.","journal-title":"World J Nephrol"},{"key":"486_CR41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.sleep.2015.10.022","volume":"20","author":"RM Elias","year":"2016","unstructured":"Elias RM, Chan CT, Bradley TD. Altered sleep structure in patients with end-stage renal disease. Sleep Med. 2016;20:67\u201371.","journal-title":"Sleep Med"},{"issue":"12","key":"486_CR42","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/eurheartj\/ehr007","volume":"32","author":"FP Cappuccio","year":"2011","unstructured":"Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484\u201392.","journal-title":"Eur Heart J"},{"issue":"9","key":"486_CR43","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kws342","volume":"177","author":"PE Peppard","year":"2013","unstructured":"Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006\u201314.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"486_CR44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12882-017-0544-3","volume":"18","author":"HC Huang","year":"2017","unstructured":"Huang HC, Walters G, Talaulikar G, Figurski D, Carroll A, Hurwitz M, et al. Sleep apnea prevalence in chronic kidney disease - association with total body water and symptoms. BMC Nephrol. 2017;18(1):125.","journal-title":"BMC Nephrol"},{"key":"486_CR45","doi-asserted-by":"crossref","unstructured":"Adams RJ, Appleton SL, Vakulin A, Hanly PJ, McDonald SP, Martin SA, et al. Chronic kidney disease and sleep apnea association of kidney disease with obstructive sleep apnea in a population study of men. Sleep. 2017;40(1).","DOI":"10.1016\/j.sleep.2017.11.009"},{"issue":"2","key":"486_CR46","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1378\/chest.10-2223","volume":"140","author":"LF Drager","year":"2011","unstructured":"Drager LF, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest. 2011;140(2):534\u201342.","journal-title":"Chest"},{"issue":"3","key":"486_CR47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1586\/14779072.2014.884460","volume":"12","author":"R Jenner","year":"2014","unstructured":"Jenner R, Lorenzi-Filho G, Drager LF. Cardiovascular impact of obstructive sleep apnea: does gender matter? Expert Rev Cardiovasc Ther. 2014;12(3):281\u20133.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"5","key":"486_CR48","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.179788","volume":"58","author":"RP Pedrosa","year":"2011","unstructured":"Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58(5):811\u20137.","journal-title":"Hypertension"},{"issue":"4","key":"486_CR49","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/ndt\/gfr605","volume":"27","author":"RM Elias","year":"2012","unstructured":"Elias RM, Bradley TD, Kasai T, Motwani SS, Chan CT. Rostral overnight fluid shift in end-stage renal disease: relationship with obstructive sleep apnea. Nephrol Dial Transplant. 2012;27(4):1569\u201373.","journal-title":"Nephrol Dial Transplant"},{"key":"486_CR50","doi-asserted-by":"crossref","unstructured":"\u2022 Stockings vs. continuous positive airway pressure on overnight fluid shift and obstructive sleep apnea among patients on hemodialysis. Frontiers in medicine. 2017;4:57. Authors show an improvement of sleep apnea by appliyng compression stockings in patients on hemodialysis.","DOI":"10.3389\/fmed.2017.00057"},{"issue":"Pt 17","key":"486_CR51","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1242\/jcs.148148","volume":"127","author":"T Hirai","year":"2014","unstructured":"Hirai T, Tanaka K, Togari A. Beta-adrenergic receptor signaling regulates Ptgs2 by driving circadian gene expression in osteoblasts. J Cell Sci. 2014;127(Pt 17):3711\u20139.","journal-title":"J Cell Sci"},{"key":"486_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.12.026","volume":"61","author":"Y Fujihara","year":"2014","unstructured":"Fujihara Y, Kondo H, Noguchi T, Togari A. Glucocorticoids mediate circadian timing in peripheral osteoclasts resulting in the circadian expression rhythm of osteoclast-related genes. Bone. 2014;61:1\u20139.","journal-title":"Bone"},{"issue":"2","key":"486_CR53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12011-013-9722-8","volume":"154","author":"I Guner","year":"2013","unstructured":"Guner I, Uzun DD, Yaman MO, Genc H, Gelisgen R, Korkmaz GG, et al. The effect of chronic long-term intermittent hypobaric hypoxia on bone mineral density in rats: role of nitric oxide. Biol Trace Elem Res. 2013;154(2):262\u20137.","journal-title":"Biol Trace Elem Res"},{"issue":"8","key":"486_CR54","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1210\/jc.2013-3629","volume":"99","author":"G Chen","year":"2014","unstructured":"Chen G, Chen L, Wen J, Yao J, Li L, Lin L, et al. Associations between sleep duration, daytime nap duration, and osteoporosis vary by sex, menopause, and sleep quality. J Clin Endocrinol Metab. 2014;99(8):2869\u201377.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"486_CR55","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11325-011-0545-6","volume":"16","author":"D Kobayashi","year":"2012","unstructured":"Kobayashi D, Takahashi O, Deshpande GA, Shimbo T, Fukui T. Association between osteoporosis and sleep duration in healthy middle-aged and elderly adults: a large-scale, cross-sectional study in Japan. Sleep Breathing. 2012;16(2):579\u201383.","journal-title":"Sleep Breathing"},{"issue":"5","key":"486_CR56","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.bone.2011.08.008","volume":"49","author":"X Fu","year":"2011","unstructured":"Fu X, Zhao X, Lu H, Jiang F, Ma X, Zhu S. Association between sleep duration and bone mineral density in Chinese women. Bone. 2011;49(5):1062\u20136.","journal-title":"Bone"},{"issue":"9","key":"486_CR57","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1258\/ebm.2012.012043","volume":"237","author":"CA Everson","year":"2012","unstructured":"Everson CA, Folley AE, Toth JM. Chronically inadequate sleep results in abnormal bone formation and abnormal bone marrow in rats. Exp Biol Med. 2012;237(9):1101\u20139.","journal-title":"Exp Biol Med"},{"issue":"4","key":"486_CR58","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jocd.2011.06.005","volume":"14","author":"K Casazza","year":"2011","unstructured":"Casazza K, Hanks LJ, Fernandez JR. Shorter sleep may be a risk factor for impaired bone mass accrual in childhood. J Clin Densitom. 2011;14(4):453\u20137.","journal-title":"J Clin Densitom"},{"issue":"10","key":"486_CR59","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.5665\/sleep.3046","volume":"36","author":"E Sforza","year":"2013","unstructured":"Sforza E, Thomas T, Barthelemy JC, Collet P, Roche F. Obstructive sleep apnea is associated with preserved bone mineral density in healthy elderly subjects. Sleep. 2013;36(10):1509\u201315.","journal-title":"Sleep"},{"issue":"3","key":"486_CR60","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.resp.2013.08.016","volume":"189","author":"M Torres","year":"2013","unstructured":"Torres M, Montserrat JM, Pavia J, Dalmases M, Ros D, Fernandez Y, et al. Chronic intermittent hypoxia preserves bone density in a mouse model of sleep apnea. Respir Physiol Neurobiol. 2013;189(3):646\u20138.","journal-title":"Respir Physiol Neurobiol"},{"key":"486_CR61","first-page":"395","volume":"5","author":"S Mariani","year":"2012","unstructured":"Mariani S, Fiore D, Varone L, Basciani S, Persichetti A, Watanabe M, et al. Obstructive sleep apnea and bone mineral density in obese patients. Diabetes Metab Syndr Obes. 2012;5:395\u2013401.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"486_CR62","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11325-012-0698-y","volume":"17","author":"H Uzkeser","year":"2013","unstructured":"Uzkeser H, Yildirim K, Aktan B, Karatay S, Kaynar H, Araz O, et al. Bone mineral density in patients with obstructive sleep apnea syndrome. Sleep Breath. 2013;17(1):339\u201342.","journal-title":"Sleep Breath"},{"issue":"4","key":"486_CR63","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0272-6386(03)00031-3","volume":"41","author":"J Takaki","year":"2003","unstructured":"Takaki J, Nishi T, Nangaku M, Shimoyama H, Inada T, Matsuyama N, et al. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney dis. 2003;41(4):833\u20139.","journal-title":"Am J Kidney dis"},{"issue":"2","key":"486_CR64","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11325-014-1049-y","volume":"19","author":"S Wali","year":"2015","unstructured":"Wali S, Shukr A, Boudal A, Alsaiari A, Krayem A. The effect of vitamin D supplements on the severity of restless legs syndrome. Sleep Breath. 2015;19(2):579\u201383.","journal-title":"Sleep Breath"},{"issue":"1","key":"486_CR65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5664\/jcsm.6396","volume":"13","author":"PD Neves","year":"2017","unstructured":"Neves PD, Graciolli FG, Oliveira IB, Bridi RA, Moyses RM, Elias RM. Effect of mineral and bone metabolism on restless legs syndrome in hemodialysis patients. J Clin Sleep Med. 2017;13(1):89\u201394.","journal-title":"J Clin Sleep Med"},{"key":"486_CR66","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","volume":"100","author":"KA Hruska","year":"2017","unstructured":"Hruska KA, Sugatani T, Agapova O, Fang Y. The chronic kidney disease - mineral bone disorder (CKD-MBD): advances in pathophysiology. Bone. 2017;100:80\u20136.","journal-title":"Bone"},{"issue":"1","key":"486_CR67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbadis.2016.10.027","volume":"1863","author":"V Metzinger-Le Meuth","year":"2017","unstructured":"Metzinger-Le Meuth V, Burtey S, Maitrias P, Massy ZA, Metzinger L. microRNAs in the pathophysiology of CKD-MBD: biomarkers and innovative drugs. Biochim Biophys Acta. 2017;1863(1):337\u201345.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"486_CR68","first-page":"1021","volume":"10","author":"SM Sprague","year":"2015","unstructured":"Sprague SM, Wetmore JB, Gurevich K, Da Roza G, Buerkert J, Reiner M, et al. Effect of cinacalcet and vitamin D analogs on fibroblast growth factor-23 during the treatment of secondary hyperparathyroidism. Clin J Am Soc. 2015;10(6):1021\u201330.","journal-title":"Clin J Am Soc"},{"issue":"8","key":"486_CR69","doi-asserted-by":"crossref","first-page":"e68870","DOI":"10.1371\/journal.pone.0068870","volume":"8","author":"PT Goldenstein","year":"2013","unstructured":"Goldenstein PT, Elias RM, Pires de Freitas do Carmo L, Coelho FO, Magalhaes LP, Antunes GL, et al. Parathyroidectomy improves survival in patients with severe hyperparathyroidism: a comparative study. PloS One. 2013;8(8):e68870.","journal-title":"PloS One"},{"issue":"6","key":"486_CR70","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2215\/CJN.10390917","volume":"13","author":"WL Lau","year":"2018","unstructured":"Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2018;13(6):952\u201361.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"486_CR71","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-016-1175-3","volume":"55","author":"M Karakose","year":"2017","unstructured":"Karakose M, Caliskan M, Arslan MS, Demirci T, Karakose S, Cakal E. The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism. Endocrine. 2017;55(1):283\u20138.","journal-title":"Endocrine"},{"issue":"5","key":"486_CR72","doi-asserted-by":"crossref","first-page":"e0155835","DOI":"10.1371\/journal.pone.0155835","volume":"11","author":"RS Santos","year":"2016","unstructured":"Santos RS, Coelho FM, Silva BC, Graciolli FG, Dominguez WV, Menezes Montenegro FL, et al. Parathyroidectomy improves restless leg syndrome in patients on hemodialysis. PLoS One. 2016;11(5):e0155835.","journal-title":"PLoS One"},{"issue":"1","key":"486_CR73","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int. 2017;92(1):26\u201336.","journal-title":"Kidney Int"},{"issue":"4","key":"486_CR74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MNH.0000000000000418","volume":"27","author":"C Steller Wagner Martins","year":"2018","unstructured":"Steller Wagner Martins C, Jorgetti V, Moyses RMA. Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2018;27(4):243\u201350.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"486_CR75","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/ndt\/gfr026","volume":"26","author":"T Isakova","year":"2011","unstructured":"Isakova T, Anderson CA, Leonard MB, Xie D, Gutierrez OM, Rosen LK, et al. Diuretics, calciuria and secondary hyperparathyroidism in the chronic renal insufficiency cohort. Nephrol Dial Transplant. 2011;26(4):1258\u201365.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"486_CR76","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000446449","volume":"43","author":"RF Vasco","year":"2016","unstructured":"\u2022 Vasco RF, Moyses RM, Zatz R, Elias RM. Furosemide increases the risk of hyperparathyroidism in chronic kidney disease. Am J Nephrol. 2016;43(6):421\u201330 The role of diuretic in CKD-MBD was the main focus in this study showing and increased risk of hyperparathyroidism with furosemide.","journal-title":"Am J Nephrol"},{"issue":"10","key":"486_CR77","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11255-017-1650-7","volume":"49","author":"RM Elias","year":"2017","unstructured":"Elias RM, Moyses RMA. Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism. Int Urol Nephrol. 2017;49(10):1815\u201321.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"486_CR78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11657-017-0326-3","volume":"12","author":"RFV Vasco","year":"2017","unstructured":"Vasco RFV, Reis ET, Moyses RMA, Elias RM. Thiazide increases serum calcium in anuric patients: the role of parathyroid hormone. Arch Osteoporos. 2017;12(1):31.","journal-title":"Arch Osteoporos"},{"issue":"6","key":"486_CR79","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/0003-4819-72-6-895","volume":"72","author":"MH Koppel","year":"1970","unstructured":"Koppel MH, Massry SG, Shinaberger JH, Hartenbower DL, Coburn JW. Thiazide-induced rise in serum calcium and magnesium in patients on maintenance hemodialysis. Ann Intern Med. 1970;72(6):895\u2013901.","journal-title":"Ann Intern Med"},{"issue":"9","key":"486_CR80","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1681\/ASN.2007030348","volume":"18","author":"MM Dvorak","year":"2007","unstructured":"Dvorak MM, De Joussineau C, Carter DH, Pisitkun T, Knepper MA, Gamba G, et al. Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. J Am Soc Nephrol. 2007;18(9):2509\u201316.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"486_CR81","doi-asserted-by":"crossref","first-page":"C22","DOI":"10.1152\/ajpcell.00289.2002","volume":"285","author":"M Brauer","year":"2003","unstructured":"Brauer M, Frei E, Claes L, Grissmer S, Jager H. Influence of K-Cl cotransporter activity on activation of volume-sensitive Cl- channels in human osteoblasts. Am J Physiol Cell Physiol. 2003;285(1):C22\u201330.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"486_CR82","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0026-0495(00)90563-8","volume":"49","author":"CH Kim","year":"2000","unstructured":"Kim CH, Kim SW, Kim GS. Effects of hydrochlorothiazide and furosemide diuretics on human bone marrow stromal osteoprogenitor cells. Metab Clin Exp. 2000;49(1):17\u201321.","journal-title":"Metab Clin Exp"},{"issue":"2","key":"486_CR83","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00198-012-2053-3","volume":"24","author":"SD Berry","year":"2013","unstructured":"Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y. Diuretic initiation and the acute risk of hip fracture. Osteoporos Int. 2013;24(2):689\u201395.","journal-title":"Osteoporos Int"},{"issue":"12","key":"486_CR84","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00424-015-1714-4","volume":"467","author":"ME Muller","year":"2015","unstructured":"Muller ME, Forni Ogna V, Maillard M, Stoudmann C, Zweiacker C, Anex C, et al. Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system. Pflugers Arch \u2013 Eur J Physiol. 2015;467(12):2413\u201321.","journal-title":"Pflugers Arch \u2013 Eur J Physiol"},{"issue":"1","key":"486_CR85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1681\/ASN.2013101033","volume":"26","author":"X Zhou","year":"2015","unstructured":"Zhou X, Chen K, Lei H, Sun Z. Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1\/CC chemokine receptor 2-mediated inflammation. J Am Soc Nephrol. 2015;26(1):121\u201332.","journal-title":"J Am Soc Nephrol"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-018-0486-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-018-0486-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-018-0486-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T17:02:37Z","timestamp":1693933357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-018-0486-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["486"],"URL":"https:\/\/doi.org\/10.1007\/s11914-018-0486-0","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"5 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Rosilene Motta Elias, Maria Aparecida Dalboni, Ana Carolina Coelho, and Rosa MA Moys\u00e9s declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}